In this study, rats in the model group showed significantly increased Keap1 expression and decreased Nrf2 and HO-1 expression, indicating weakened anti-inflammatory and antioxidant capacity in NAFLD rats. The gene discussed is KEAP1; the disease is metabolic dysfunction-associated steatotic liver disease.